What is Sinopharm Group Co Earnings Yield (Joel Greenblatt) %?
Sinopharm Group Co's Enterprise Value for the quarter that ended in Dec. 2024 was $18,067 Mil.
Sinopharm Group Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2024 was $2,303 Mil. Sinopharm Group Co's Earnings Yield (Joel Greenblatt) for the quarter that ended in Dec. 2024 was 12.63%.
The historical rank and industry rank for Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % or its related term are showing as below:
SHTDY'
s Earnings Yield (Joel Greenblatt) % Range Over the Past 10 Years
Min: 7.97 Med: 14.25 Max: 21.78
Current: 13.53
During the past 13 years, the highest Earnings Yield (Joel Greenblatt) of Sinopharm Group Co was 21.78%. The lowest was 7.97%. And the median was 14.25%.
SHTDY's Earnings Yield (Joel Greenblatt) % is ranked better than 77.39% of 115
companies
in the Medical Distribution industry
Industry Median: 5.98
vs SHTDY: 13.53
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
A better indicator of the attractiveness of an investment which takes growth into account is the Forward Rate of Return (Yacktman) %. Sinopharm Group Co's Forward Rate of Return (Yacktman) % for the quarter that ended in Dec. 2024 was 21.48%. The Forward Rate of Return uses the normalized Free Cash Flow of the past five years, and considers growth. The forward rate of return can be thought of as the return that investors buying the stock today can expect from it in the future.
Sinopharm Group Co Earnings Yield (Joel Greenblatt) % Historical Data
The historical data trend for Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
Sinopharm Group Co Earnings Yield (Joel Greenblatt) % Chart
Competitive Comparison of Sinopharm Group Co's Earnings Yield (Joel Greenblatt) %
For the Medical Distribution subindustry, Sinopharm Group Co's Earnings Yield (Joel Greenblatt) %, along with its competitors' market caps and Earnings Yield (Joel Greenblatt) % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % Distribution in the Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % distribution charts can be found below:
* The bar in red indicates where Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % falls into.
Sinopharm Group Co Earnings Yield (Joel Greenblatt) % Calculation
In his book, The Little That Beat the Market, hedge fund manager Joel Greenblatt defines Earnings Yield as operating income divided by enterprise value.
Sinopharm Group Cos Earnings Yield (Joel Greenblatt) for the fiscal year that ended in Dec. 2024 is calculated as
For company reported semi-annually or annually, GuruFocus only calculate annual data for Earnings Yield (Joel Greenblatt) and apply the annual figure to corresponding quarter.
Sinopharm Group Co (OTCPK:SHTDY) Earnings Yield (Joel Greenblatt) % Explanation
Joel Greenblatt defines the earnings yield using the above equation because it more accurately reflects the company's profitability relative to its stock price. Items like interest payment and tax etc. are not directly related to the company's operational profitability.
Enterprise Value instead of market cap (share price) is used in the calculation because it is the real price stock and bond investors together pay for the company.
Be Aware
Joel Greenblatt's definition of earnings yield has the same problems the regular earnings yield does. It does not consider the growth of the company. It only looks at one-year's business operation. For cyclical companies, the earnings yield is usually highest at the peak of the business cycle. But these earnings are rarely sustainable.
Sinopharm Group Co Earnings Yield (Joel Greenblatt) % Related Terms
Thank you for viewing the detailed overview of Sinopharm Group Co's Earnings Yield (Joel Greenblatt) % provided by GuruFocus.com. Please click on the following links to see related term pages.
Founded in 2003, Sinopharm is the largest wholesaler and retailer of drugs and medical devices in China and listed on the Hong Kong Stock Exchange in 2009. It is a core subsidiary of China National Pharmaceutical Group. Sinopharm's largest operating segment is pharmaceutical distribution, making up over 70% of its total revenue by the end of 2024. In 2018, Sinopharm acquired the largest Chinese medical device distributor, China National Scientific Instruments and Materials. Now, medical device distribution accounts for over 20% of Sinopharm's total revenue. Sinopharm's downstream customers range from hospitals and other health services institutions to end-customers.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SHTDY has been successfully added to your 